# Regulation of Cell Proliferation and Migration by Extracellular Phosphatidic Acid

**Authors:** Ana Gomez-Larrauri, Asier Benito-Vicente, Kepa B. Uribe, Cesar Martin, Antonio Gomez-Muñoz

PMC · DOI: 10.3390/biomedicines14030616 · Biomedicines · 2026-03-10

## TL;DR

This paper reviews how extracellular phosphatidic acid influences cell growth and migration, particularly in muscle regeneration and lung cancer.

## Contribution

The paper highlights new insights into extracellular PA's role in regulating cell functions through LPA receptor interactions and downstream signaling pathways.

## Key findings

- Extracellular PA stimulates myoblast proliferation and lung cancer cell migration.
- PA's effects are mediated through LPA receptors and activation of MEK/ERK, PI3K/Akt, FAK/Rac1, and JAK2/STAT3 pathways.
- These findings suggest potential therapeutic strategies for lung cancer dissemination.

## Abstract

Phosphatidic acid (PA) is increasingly recognized as an important endogenous regulator of cell proliferation and migration, playing relevant roles in physiology and pathology. However, the potential and prominence of extracellular PA in controlling cell functions are not so well established. The present review article has been undertaken to update and discuss the latest findings on extracellular PA as regulator of cell homeostasis, with special attention being paid to its role in the regulation of cell growth and migration. Specifically, exogenous PA potently stimulates myoblast proliferation and lung cancer cell migration, pointing to a critical role of this glycerophospholipid in the regulation of muscle cell regeneration and lung cancer dissemination. Interestingly, both of these actions are mediated through interaction of PA with lysophosphatidic acid (LPA) receptors and the subsequent activation of different signal transduction pathways. In particular, PA induces mitogen-activated protein kinase kinase (MEK)/extracellularly regulated kinases (ERK) 1 and 2, phosphatidylinositol 3-kinase (PI3K)/Akt, focal adhesion kinase (FAK)/Rac1, and Janus kinase-2 (JAK2)/signal transducer and activator of transcription 3 (STAT3). These findings may contribute to a better understanding of muscle cell biology and may help to develop new therapeutic strategies to treat lung cancer dissemination.

## Linked entities

- **Proteins:** MAP2K7 (mitogen-activated protein kinase kinase 7), MAPK3 (mitogen-activated protein kinase 3), MAPK1 (mitogen-activated protein kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), PTK2 (protein tyrosine kinase 2), RAC1 (Rac family small GTPase 1), JAK2 (Janus kinase 2), STAT3 (signal transducer and activator of transcription 3)
- **Chemicals:** phosphatidic acid (PubChem CID 446066), lysophosphatidic acid (PubChem CID 5497152)
- **Diseases:** lung cancer (MONDO:0005138)

## Full-text entities

- **Genes:** STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}
- **Diseases:** lung cancer (MESH:D008175)
- **Chemicals:** PA (MESH:D010712), glycerophospholipid (MESH:D020404)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024409/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024409/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024409/full.md

---
Source: https://tomesphere.com/paper/PMC13024409